CA2549191A1 - Improved ocular lens - Google Patents
Improved ocular lens Download PDFInfo
- Publication number
- CA2549191A1 CA2549191A1 CA002549191A CA2549191A CA2549191A1 CA 2549191 A1 CA2549191 A1 CA 2549191A1 CA 002549191 A CA002549191 A CA 002549191A CA 2549191 A CA2549191 A CA 2549191A CA 2549191 A1 CA2549191 A1 CA 2549191A1
- Authority
- CA
- Canada
- Prior art keywords
- lens device
- ocular lens
- polyisobutylene
- ocular
- copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
- A61F2/1629—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing longitudinal position, i.e. along the visual axis when implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/169—Surrounding optic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Abstract
An ocular lens (32) has a refractive optics structure formed from a polyisobutylene-based material and a glassy segment that is non-reactive to ocular fluid and that maintains in vivo transparency for a substantial time period. The material has a central elastomeric polyolefinic block and thermoplastic end blocks (such as a triblock polymer backbone comprising polystyrene-polyisobutylene-polystyrene). The material is preferably flexible such that the refractive optics structure can be folded upon itself and introduced through a small scleral incision. The lens device includes an optic portion and preferably either an annular haptic element or one or more haptic elements adapted to rest within a capsular bag formed by a surgical procedure.
A portion of the lens device may be loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye to protect against PCO.
A portion of the lens device may be loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye to protect against PCO.
Claims (54)
1. An ocular lens device comprising:
a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, wherein the copolymer is formulated to maintain in vivo transparency for at least two months.
a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, wherein the copolymer is formulated to maintain in vivo transparency for at least two months.
2. An ocular lens device according to claim 1, wherein:
said copolymer is flexible such that said refractive optics structure can be folded or rolled upon itself.
said copolymer is flexible such that said refractive optics structure can be folded or rolled upon itself.
3. An ocular lens device according to claim 2, wherein:
said ocular lens device is foldable such that it can be introduced through a small scleral incision.
said ocular lens device is foldable such that it can be introduced through a small scleral incision.
4. An ocular lens device according to claim 3, wherein:
said small sclera incision comprises a slit having a length of 2 mm or less.
said small sclera incision comprises a slit having a length of 2 mm or less.
5. An ocular lens device according to claim 1, wherein:
said glassy segment does not contain any cleavable group which will release in the presence of ocular fluid.
said glassy segment does not contain any cleavable group which will release in the presence of ocular fluid.
6. An ocular lens device according to claim 1, wherein:
said glassy segment comprises a vinyl aromatic polymer.
said glassy segment comprises a vinyl aromatic polymer.
7. An ocular lens device according to claim 5, wherein:
said vinyl aromatic polymer comprises at least one of polystyrene, and .alpha.-methylstyrene.
said vinyl aromatic polymer comprises at least one of polystyrene, and .alpha.-methylstyrene.
8. An ocular lens device according to claim 1, wherein:
said glassy segment comprises a methacrylate polymer.
said glassy segment comprises a methacrylate polymer.
9. An ocular lens device according to claim 8, wherein:
said methactylate polymer comprises at least one of methylmethacrylate, ethylmethacrylate, and hydroxymethalcrylate.
said methactylate polymer comprises at least one of methylmethacrylate, ethylmethacrylate, and hydroxymethalcrylate.
10. An ocular lens device according to claim 1, wherein:
said non-cross-linked polyisobutylene-based material has a general block structure with a central elastomeric polyolefinic block and thermoplastic end blocks.
said non-cross-linked polyisobutylene-based material has a general block structure with a central elastomeric polyolefinic block and thermoplastic end blocks.
11. An ocular lens device according to claim 10, wherein:
said non-cross-linked polyisobutylene-based material comprises a triblock polymer backbone comprising polystyrene-polyisobutylene-polystyrene.
said non-cross-linked polyisobutylene-based material comprises a triblock polymer backbone comprising polystyrene-polyisobutylene-polystyrene.
12. An ocular lens device according to claim 10, wherein:
said non-cross-linked polyisobutylene-based material has a general block structure selected from one of the following:
a) BAB or ABA, b) B(AB)o or A(BA)n, and c) X-(AB)n or X-(BA)n;
where A is an elastomeric polyolefinic block, B is a thermoplastic block, n is a positive whole number and X is a starting seed molecule.
said non-cross-linked polyisobutylene-based material has a general block structure selected from one of the following:
a) BAB or ABA, b) B(AB)o or A(BA)n, and c) X-(AB)n or X-(BA)n;
where A is an elastomeric polyolefinic block, B is a thermoplastic block, n is a positive whole number and X is a starting seed molecule.
13. An ocular lens device according to claim 12, wherein:
said non-cross-linked polyisobutylene-based material comprises one of a star-shaped block copolymer (where n=3 or more) and multi-dendrite-shaped block copolymer.
said non-cross-linked polyisobutylene-based material comprises one of a star-shaped block copolymer (where n=3 or more) and multi-dendrite-shaped block copolymer.
14. An ocular lens device according to claim 1, further comprising:
an optic portion and at least one haptic element that are adapted to rest within a capsular bag formed by a surgical procedure, wherein said at least one haptic element supports said optic portion.
an optic portion and at least one haptic element that are adapted to rest within a capsular bag formed by a surgical procedure, wherein said at least one haptic element supports said optic portion.
15. An ocular lens device according to claim 14, wherein:
said at least one haptic element comprises a plurality of haptic elements that project radially away from said optic portion.
said at least one haptic element comprises a plurality of haptic elements that project radially away from said optic portion.
16. An ocular lens device according to claim 14, wherein:
said at least one haptic element comprises an annular surface that extends radially outward from said optic portion.
said at least one haptic element comprises an annular surface that extends radially outward from said optic portion.
17. An ocular lens device according to claim 16, wherein:
said optic region is substantially disposed along a plane that is perpendicular to the optical axis of the eye, and said annular surface projects radially outward from said optic portion at an angle relative to said plane, said angle between 0 and 45 degrees.
said optic region is substantially disposed along a plane that is perpendicular to the optical axis of the eye, and said annular surface projects radially outward from said optic portion at an angle relative to said plane, said angle between 0 and 45 degrees.
18. An ocular lens device according to claim 17, wherein:
said angle is between 10 and 20 degrees.
said angle is between 10 and 20 degrees.
19. An ocular lens device according to claim 18, wherein:
said angle is 15 degrees.
said angle is 15 degrees.
20. An ocular lens device according to claim 14, wherein:
said optic portion has a front convex surface and a flat back surface.
said optic portion has a front convex surface and a flat back surface.
21. An ocular lens device according to claim 14, wherein:
said optic portion has a stepped wall structure at its periphery.
said optic portion has a stepped wall structure at its periphery.
22. An ocular lens device according to claim 14; wherein:
said optic portion and said at least one haptic element are formed from said material.
said optic portion and said at least one haptic element are formed from said material.
23. An ocular lens device according to claim 14, wherein:
said optic portion is formed from said material, and said at least one haptic element is formed from a different material.
said optic portion is formed from said material, and said at least one haptic element is formed from a different material.
24. An ocular lens device according to claim 1, wherein:
said non-cross-linked polyisobutylene-based material blocks ultra-violet light.
said non-cross-linked polyisobutylene-based material blocks ultra-violet light.
25. An ocular lens device according to claim 1, wherein:
said copolymer is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
said copolymer is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
26. An ocular lens device according to claim 25, wherein:
said at least one therapeutic agent is selected from the group of cytostatic agents and anti-migratory agents.
said at least one therapeutic agent is selected from the group of cytostatic agents and anti-migratory agents.
27. An ocular lens device according to claim 25, wherein:
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
28. An ocular lens device according to claim 1, wherein:
said refractive optics structure is adapted for intraocular disposition in one of the anterior chamber of the eye, the posterior chamber of the eye , and the vitreous chamber of the eye.
said refractive optics structure is adapted for intraocular disposition in one of the anterior chamber of the eye, the posterior chamber of the eye , and the vitreous chamber of the eye.
29. An ocular lens device according to claim 1, wherein:
said non-cross-linked polyisobutylene-based material is formed by a polyisobutylene-based polymer with substantially all remnant salts washed from the polyisobutylene-based polymer.
said non-cross-linked polyisobutylene-based material is formed by a polyisobutylene-based polymer with substantially all remnant salts washed from the polyisobutylene-based polymer.
30. An ocular lens device according to claim 29, wherein:
the refractive optics structure is formed and molded at temperatures that are significantly less that the melting point of the polyisobutylene-based polymer.
the refractive optics structure is formed and molded at temperatures that are significantly less that the melting point of the polyisobutylene-based polymer.
31. An ocular lens device according to claim 29, wherein:
the refractive optics structure is formed by compression molding in conjunction with rapid heating to a temperature at or near the melting point of the polyisobutylene-based polymer and rapid cooling.
the refractive optics structure is formed by compression molding in conjunction with rapid heating to a temperature at or near the melting point of the polyisobutylene-based polymer and rapid cooling.
32. An ocular lens device according to claim 31, wherein:
time duration encompassing the rapid hearing and the rapid cooling defines a heating-cooling cycle that is less than three minutes.
time duration encompassing the rapid hearing and the rapid cooling defines a heating-cooling cycle that is less than three minutes.
33 33. An ocular lens device according to claim 32, wherein:
said heat-cooling cycle is less than one minute.
said heat-cooling cycle is less than one minute.
34. An ocular lens device according to claim 30, wherein:
said non-cross-linked polyisobutylene-based material is formed by dissolving said polyisobutylene-based polymer in a solvent to form a solution and casting the solution.
said non-cross-linked polyisobutylene-based material is formed by dissolving said polyisobutylene-based polymer in a solvent to form a solution and casting the solution.
35. An ocular lens device according to claim 34, wherein:
the casting of the solution forms at least one lens preform, and said refractive optics structure is formed by compression molding of said at least one lens preform.
the casting of the solution forms at least one lens preform, and said refractive optics structure is formed by compression molding of said at least one lens preform.
36. An ocular lens device comprising:
a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, said non-cross-linked polyisobutylene-based material derived from a polyisobutylene-based polymer that is washed to substantially remove remnant salts from the polyisobutylene-based polymer.
a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, said non-cross-linked polyisobutylene-based material derived from a polyisobutylene-based polymer that is washed to substantially remove remnant salts from the polyisobutylene-based polymer.
37. An ocular lens device according to claim 36, wherein:
the refractive optics structure is formed and molded at temperatures that are significantly less that the melting point of the polyisobutylene-based polymer.
the refractive optics structure is formed and molded at temperatures that are significantly less that the melting point of the polyisobutylene-based polymer.
38. An ocular lens device according to claim 36, wherein:
the refractive optics structure is formed by compression molding in conjunction with rapid heating to a temperature at or near the melting point of the polyisobutylene-based polymer and rapid cooling.
the refractive optics structure is formed by compression molding in conjunction with rapid heating to a temperature at or near the melting point of the polyisobutylene-based polymer and rapid cooling.
39. An ocular lens device according to claim 38, wherein:
time duration encompassing the rapid heating and the rapid cooling defines a heating-cooling cycle that is less than three minutes.
time duration encompassing the rapid heating and the rapid cooling defines a heating-cooling cycle that is less than three minutes.
40. An ocular lens device according to claim 39, wherein:
said heat-cooling cycle is less than one minute.
said heat-cooling cycle is less than one minute.
41. An ocular lens device according to claim 37, wherein:
said non-cross-linked polyisobutylene-based material is formed by dissolving the washed polyisobutylene-based polymer in a solvent to form a solution and casting the solution.
said non-cross-linked polyisobutylene-based material is formed by dissolving the washed polyisobutylene-based polymer in a solvent to form a solution and casting the solution.
42. An ocular lens device comprising:
a refractive optics structure formed from a copolymer of a non-cross-linked polyisoburylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment and being flexible such that said refractive optics structure can be folded or rolled upon itself.
a refractive optics structure formed from a copolymer of a non-cross-linked polyisoburylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment and being flexible such that said refractive optics structure can be folded or rolled upon itself.
43. An ocular lens device according to claim 42, wherein:
said ocular lens device is foldable such that it can be introduced through a small scleral incision.
said ocular lens device is foldable such that it can be introduced through a small scleral incision.
44. An ocular lens device according to claim 43, wherein:
said small sclera incision comprises a slit having a length of 2 mm or less.
said small sclera incision comprises a slit having a length of 2 mm or less.
45. An ocular lens device comprising:
a structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, wherein said copolymer is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
a structure formed from a copolymer of a non-cross-linked polyisobutylene-based material with a glassy segment, the copolymer being non-reactive in an ocular environment, wherein said copolymer is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
46. An ocular lens device according to claim 45, wherein:
said at least one therapeutic agent is selected from the groups of cytostatic agents and anti-migratory agents.
said at least one therapeutic agent is selected from the groups of cytostatic agents and anti-migratory agents.
47. An ocular lens device according to claim 45, wherein:
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
48. A surgical method comprising:
providing an intraocular lens device including a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material and a glassy segment, the copolymer being non-reactive in the intended ocular environment of the device and being-formulated to maintain in vivo transparency for at least two months, and wherein said intraocular lens device is flexible such that it can be folded or rolled upon itself;
folding or rolling said intraocular lens device upon itself and inserting the folded or rolled intraocular lens device through a scleral incision; and unfolding or unrolling said intraocular lens device and positioning said intraocular lens device such that it is supported within a capsulary bag.
providing an intraocular lens device including a refractive optics structure formed from a copolymer of a non-cross-linked polyisobutylene-based material and a glassy segment, the copolymer being non-reactive in the intended ocular environment of the device and being-formulated to maintain in vivo transparency for at least two months, and wherein said intraocular lens device is flexible such that it can be folded or rolled upon itself;
folding or rolling said intraocular lens device upon itself and inserting the folded or rolled intraocular lens device through a scleral incision; and unfolding or unrolling said intraocular lens device and positioning said intraocular lens device such that it is supported within a capsulary bag.
49. The surgical method of claim 48, wherein:
the size of the scleral incision is small.
the size of the scleral incision is small.
50. The surgical method of claim 49, wherein:
the sclera incision comprises a slit having a length of 2 mm or less.
the sclera incision comprises a slit having a length of 2 mm or less.
51. The surgical method of claim 48, further comprising:
forming the scleral incision;
inserting tooling through the scleral incision and manipulating the tooling to tear the anterior capsule wall of the human eye to form a capsulary bag defined by a remaining portion of the anterior capsule wall and the posterior capsule wall of the human eye;
and removing at least a portion of the natural crystalline lens of the human eye through the scleral incision;
forming the scleral incision;
inserting tooling through the scleral incision and manipulating the tooling to tear the anterior capsule wall of the human eye to form a capsulary bag defined by a remaining portion of the anterior capsule wall and the posterior capsule wall of the human eye;
and removing at least a portion of the natural crystalline lens of the human eye through the scleral incision;
52. The surgical method of claim 48, wherein:
a portion of said intraocular lens device is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
a portion of said intraocular lens device is loaded with at least one therapeutic agent that interferes with proliferation of the epithelial cells of the eye.
53. The surgical method of claim 52, wherein:
said at least one therapeutic agent is selected from the groups of cytostatic agents and anti-migratory agents.
said at least one therapeutic agent is selected from the groups of cytostatic agents and anti-migratory agents.
54. The surgical method of claim 53, wherein:
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
said at least one therapeutic agent comprises paclitaxel or an analog of paclitaxel.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52696503P | 2003-12-05 | 2003-12-05 | |
US52696603P | 2003-12-05 | 2003-12-05 | |
US60/526,966 | 2003-12-05 | ||
US60/526,965 | 2003-12-05 | ||
PCT/US2004/040447 WO2005057272A2 (en) | 2003-12-05 | 2004-12-03 | Improved ocular lens |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2549191A1 true CA2549191A1 (en) | 2005-06-23 |
CA2549191C CA2549191C (en) | 2012-10-23 |
Family
ID=34681520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2549191A Expired - Fee Related CA2549191C (en) | 2003-12-05 | 2004-12-03 | Improved ocular lens |
Country Status (6)
Country | Link |
---|---|
US (3) | US7794498B2 (en) |
EP (1) | EP1696831B1 (en) |
JP (1) | JP5009623B2 (en) |
AU (1) | AU2004297967C1 (en) |
CA (1) | CA2549191C (en) |
WO (1) | WO2005057272A2 (en) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060238702A1 (en) | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
FR2833154B1 (en) | 2001-12-12 | 2004-11-19 | Ioltechnologie Production | CASSETTE AND FLEXIBLE INTRAOCULAR LENS INJECTOR AND METHOD FOR INJECTING SUCH LENSES |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US10045844B2 (en) | 2002-02-02 | 2018-08-14 | Powervision, Inc. | Post-implant accommodating lens modification |
US20070100445A1 (en) * | 2003-02-03 | 2007-05-03 | Shadduck John H | Intraocular lenses and business methods |
US7842377B2 (en) | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US7662180B2 (en) | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
US7217288B2 (en) | 2002-12-12 | 2007-05-15 | Powervision, Inc. | Accommodating intraocular lens having peripherally actuated deflectable surface and method |
US8328869B2 (en) | 2002-12-12 | 2012-12-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
US10835373B2 (en) | 2002-12-12 | 2020-11-17 | Alcon Inc. | Accommodating intraocular lenses and methods of use |
US8361145B2 (en) | 2002-12-12 | 2013-01-29 | Powervision, Inc. | Accommodating intraocular lens system having circumferential haptic support and method |
AU2004219674A1 (en) | 2003-03-06 | 2004-09-23 | Powervision, Inc. | Adaptive optic lens and method of making |
WO2005055875A2 (en) * | 2003-12-09 | 2005-06-23 | Advanced Medical Optics, Inc. | Foldable intraocular lens and method of making |
US7615073B2 (en) * | 2003-12-09 | 2009-11-10 | Advanced Medical Optics, Inc. | Foldable intraocular lens and method of making |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
IL161706A0 (en) | 2004-04-29 | 2004-09-27 | Nulens Ltd | Intraocular lens fixation device |
US9872763B2 (en) | 2004-10-22 | 2018-01-23 | Powervision, Inc. | Accommodating intraocular lenses |
US8235728B2 (en) * | 2004-11-13 | 2012-08-07 | Stuart Stoll | Apparatus for practicing ophthalmologic surgical techniques |
CA2601351A1 (en) | 2005-03-30 | 2006-10-05 | Nulens Ltd | Accommodating intraocular lens (aiol) assemblies, and discrete components therfor |
US8097033B2 (en) * | 2005-06-16 | 2012-01-17 | The University Of Miami | Extraocular muscle prosthesis |
EP1924222A1 (en) * | 2005-08-05 | 2008-05-28 | Visiogen, Inc. | Accommodating diffractive intraocular lens |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
US7947368B2 (en) * | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
US20070168027A1 (en) * | 2006-01-13 | 2007-07-19 | Brady Daniel G | Accommodating diffractive intraocular lens |
CN1810301B (en) * | 2006-01-24 | 2012-07-04 | 广州卫视博生物科技有限公司 | Artificial hyaloid capsule bag and its making process |
US8190266B2 (en) * | 2006-02-15 | 2012-05-29 | Dohey Eye Institute | Wide-field retinal prosthesis |
US7559949B2 (en) * | 2006-04-28 | 2009-07-14 | Leonard Pinchuk | Injectable intraocular lens that minimizes posterior capsule opacification and methods and materials for realizing same |
US8002828B2 (en) * | 2006-04-28 | 2011-08-23 | Leonard Pinchuk | Method of implantation using polymer adhesive for an intraocular lens that minimizes posterior capsule opacification |
US20070260308A1 (en) * | 2006-05-02 | 2007-11-08 | Alcon, Inc. | Accommodative intraocular lens system |
US9375217B2 (en) | 2006-07-18 | 2016-06-28 | Boston Scientific Scimed, Inc. | Catheterizing body lumens |
WO2008030939A2 (en) * | 2006-09-06 | 2008-03-13 | Innovia, Llc | Porous polymeric material particularly suited for medical implant applications |
ZA200903649B (en) * | 2006-12-18 | 2010-08-25 | Alcon Res Ltd | Devices and methods for ophthalmic drug delivery |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US8158712B2 (en) | 2007-02-21 | 2012-04-17 | Powervision, Inc. | Polymeric materials suitable for ophthalmic devices and methods of manufacture |
US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
US9610155B2 (en) | 2008-07-23 | 2017-04-04 | Powervision, Inc. | Intraocular lens loading systems and methods of use |
WO2009015226A2 (en) | 2007-07-23 | 2009-01-29 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
US8314927B2 (en) * | 2007-07-23 | 2012-11-20 | Powervision, Inc. | Systems and methods for testing intraocular lenses |
US8668734B2 (en) | 2010-07-09 | 2014-03-11 | Powervision, Inc. | Intraocular lens delivery devices and methods of use |
JP5426547B2 (en) | 2007-07-23 | 2014-02-26 | パワーヴィジョン・インコーポレーテッド | Lens delivery system |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
EP2384167A4 (en) * | 2009-01-09 | 2016-02-17 | Powervision Inc | Intraocular lenses and methods of accounting for capsule size variability and post-implant changes in the eye |
US10299913B2 (en) | 2009-01-09 | 2019-05-28 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
WO2010101758A1 (en) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | Peri-corneal drug delivery device |
WO2010129905A1 (en) * | 2009-05-08 | 2010-11-11 | Innolene Llc | Ocular lens |
CN102596097B (en) | 2009-06-03 | 2015-05-20 | 弗赛特实验室有限责任公司 | Anterior segment drug delivery |
US8486142B2 (en) | 2009-06-26 | 2013-07-16 | Abbott Medical Optics Inc. | Accommodating intraocular lenses |
KR20110006022A (en) * | 2009-07-13 | 2011-01-20 | 삼성전자주식회사 | Operation method for imaging processing f portable device and apparatus using the same |
AU2010279561B2 (en) | 2009-08-03 | 2014-11-27 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens for providing accomodative vision |
JP5894076B2 (en) | 2009-08-31 | 2016-03-23 | パワーヴィジョン・インコーポレーテッド | Lens capsule size estimation method |
JP2013520291A (en) | 2010-02-23 | 2013-06-06 | パワーヴィジョン・インコーポレーテッド | Liquid for accommodation type intraocular lens |
US10278810B2 (en) | 2010-04-29 | 2019-05-07 | Ojo, Llc | Injectable physiologically adaptive intraocular lenses (IOL's) |
US9220590B2 (en) | 2010-06-10 | 2015-12-29 | Z Lens, Llc | Accommodative intraocular lens and method of improving accommodation |
AU2011317283B2 (en) * | 2010-10-18 | 2015-11-05 | University Of Utah Research Foundation | Vision correction system |
US8678593B2 (en) * | 2010-10-26 | 2014-03-25 | Alcon Research, Ltd. | Ophthalmoscopic contact lens |
CN103403184A (en) * | 2010-12-23 | 2013-11-20 | 劳伦特·亚历山大 | Method to obtain optical means adapted to a human individual suffering or susceptible to suffer from one or more genetic related eye disorder(s) or disease(s) |
US20120191185A1 (en) * | 2011-01-26 | 2012-07-26 | Micheal Colvin | Ophthalmic intraocular lens for promoting healing |
EP3685801A1 (en) | 2011-02-04 | 2020-07-29 | ForSight Vision6, Inc. | Intraocular accommodating lens |
US9186243B2 (en) * | 2011-05-31 | 2015-11-17 | Novartis Ag | Accommodative intraocular lens and method of implantation |
US9372282B1 (en) * | 2011-08-31 | 2016-06-21 | Novartis Ag | Styrenic ophthalmic and otorhinolaryngological materials and devices formed therewith |
CN106073986B (en) * | 2011-09-14 | 2019-01-11 | 弗赛特影像5股份有限公司 | The device for treating the eyes of patient |
US10433949B2 (en) | 2011-11-08 | 2019-10-08 | Powervision, Inc. | Accommodating intraocular lenses |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
US9364318B2 (en) | 2012-05-10 | 2016-06-14 | Z Lens, Llc | Accommodative-disaccommodative intraocular lens |
RU2526248C2 (en) * | 2012-09-20 | 2014-08-20 | Общество с ограниченной ответственностью предприятие "Репер-НН" | Iridolenticular block |
US9750636B2 (en) | 2012-10-26 | 2017-09-05 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
US9486311B2 (en) | 2013-02-14 | 2016-11-08 | Shifamed Holdings, Llc | Hydrophilic AIOL with bonding |
ES2834479T3 (en) | 2013-03-15 | 2021-06-17 | Alcon Inc | Method of reconfiguring an intraocular lens for delivery to a delivery device |
US10195018B2 (en) | 2013-03-21 | 2019-02-05 | Shifamed Holdings, Llc | Accommodating intraocular lens |
CA3193600A1 (en) | 2013-03-21 | 2014-09-25 | Shifamed Holdings, Llc | Accommodating intraocular lens |
BR112015029651A8 (en) * | 2013-05-30 | 2018-04-03 | Senju Pharma Co | ANNULAR DEVICE TO BE USED ON A SCLEROTIC SURFACE |
WO2015148673A1 (en) | 2014-03-28 | 2015-10-01 | Forsight Labs, Llc | Accommodating intraocular lens |
JP6267832B2 (en) | 2014-08-26 | 2018-01-24 | シファメド・ホールディングス・エルエルシー | Adjustable intraocular lens |
US11938018B2 (en) | 2014-09-22 | 2024-03-26 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders |
US10299910B2 (en) | 2014-09-22 | 2019-05-28 | Kevin J. Cady | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10945832B2 (en) | 2014-09-22 | 2021-03-16 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11109957B2 (en) | 2014-09-22 | 2021-09-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10159562B2 (en) | 2014-09-22 | 2018-12-25 | Kevin J. Cady | Intraocular pseudophakic contact lenses and related systems and methods |
EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
WO2017079733A1 (en) | 2015-11-06 | 2017-05-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of manufacturing |
US11141263B2 (en) | 2015-11-18 | 2021-10-12 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lens |
US10512535B2 (en) | 2016-08-24 | 2019-12-24 | Z Lens, Llc | Dual mode accommodative-disaccomodative intraocular lens |
EA037705B1 (en) | 2016-10-28 | 2021-05-12 | Форсайт Вижн6, Инк. | Accommodating intraocular lens and system for implantation in an eye |
US10350056B2 (en) | 2016-12-23 | 2019-07-16 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lenses and methods for making and using same |
JP7370052B2 (en) | 2017-05-30 | 2023-10-27 | シファメド・ホールディングス・エルエルシー | Surface treatments and related methods and devices for accommodating intraocular lenses |
WO2018227014A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Adjustable optical power intraocular lenses |
EP3681438A1 (en) | 2017-09-11 | 2020-07-22 | AMO Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
KR101978860B1 (en) * | 2019-03-18 | 2019-05-15 | 정태선 | Therapeutic contact lens |
WO2021067574A1 (en) | 2019-10-04 | 2021-04-08 | Alcon Inc. | Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses |
US11759309B2 (en) | 2020-04-29 | 2023-09-19 | Long Bridge Medical, Inc. | Devices to support and position an intraocular lens within the eye and methods of use |
USD1006087S1 (en) * | 2021-09-10 | 2023-11-28 | Aperture In Motion, LLC | Contact lens |
USD1019728S1 (en) * | 2021-09-10 | 2024-03-26 | Aperture In Motion, LLC | Contact lens |
USD1006086S1 (en) * | 2021-09-10 | 2023-11-28 | Aperture In Motion, LLC | Contact lens |
US20230293288A1 (en) * | 2022-03-15 | 2023-09-21 | Desikan Raiguru Kadambi | Implantable accomodating intraocular lenses, iol implants, and related systems and methods |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2674743A (en) * | 1950-09-21 | 1954-04-13 | Romey A Gaiser | Therapeutic, cosmetic, and corrective device |
US4186184A (en) * | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
US4253199A (en) * | 1978-09-25 | 1981-03-03 | Surgical Design Corporation | Surgical method and apparatus for implants for the eye |
US4254509A (en) * | 1979-04-09 | 1981-03-10 | Tennant Jerald L | Accommodating intraocular implant |
EP0024126A1 (en) * | 1979-07-26 | 1981-02-25 | David Peter Choyce | Autoclavable intraocular lens for implantation in the anterior chamber of the eye |
US4452776A (en) * | 1979-08-20 | 1984-06-05 | Eye Research Institute Of Retina Foundation | Hydrogel implant article and method |
US4276394A (en) * | 1979-09-10 | 1981-06-30 | The University Of Akron | Novel telechelic polymers, block copolymers and processes for the preparation thereof |
US4342849A (en) * | 1979-09-10 | 1982-08-03 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
US4316973A (en) * | 1979-09-10 | 1982-02-23 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
US4298996A (en) | 1980-07-23 | 1981-11-10 | Barnet Ronald W | Magnetic retention system for intraocular lens |
US4601720A (en) * | 1981-02-24 | 1986-07-22 | Sinskey Robert M | Intraocular lens assembly |
US5776191A (en) * | 1982-02-05 | 1998-07-07 | Staar Surgical Company | Fixation system for intraocular lens structures |
US4578078A (en) * | 1982-04-02 | 1986-03-25 | Minnesota Mining And Manufacturing Company | Intraocular lens with asymetric vaulted support loops |
US4897255A (en) | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US5122572A (en) * | 1985-06-20 | 1992-06-16 | Kennedy Joseph P | Living catalysts, complexes and polymers therefrom |
US4910321A (en) * | 1985-06-20 | 1990-03-20 | University Of Akron | Living catalysts, complexes and polymers therefrom |
US4661573A (en) * | 1986-04-14 | 1987-04-28 | Paragon Optical Inc. | Lens composition articles and method of manufacture |
US4704123A (en) * | 1986-07-02 | 1987-11-03 | Iolab Corporation | Soft intraocular lens |
US4752627A (en) | 1986-08-13 | 1988-06-21 | Michael Froix | Clouding-resistant contact lens compositions |
US4929683A (en) * | 1986-08-25 | 1990-05-29 | University Of Akron | Living polymerization of olefin to end-functionalized polymers |
US5066730A (en) * | 1986-08-25 | 1991-11-19 | The University Of Akron | Living polymerization of olefins to end-functionalized polymers |
US4842601A (en) | 1987-05-18 | 1989-06-27 | Smith S Gregory | Accommodating intraocular lens and method of implanting and using same |
US4866866A (en) * | 1987-11-09 | 1989-09-19 | Rotter Bernard J | Collapsible sign |
US4904421A (en) * | 1987-11-25 | 1990-02-27 | Tomei Sangyo Kabushiki Kaisha | Soft ocular lens and method for its preparation |
US4886866A (en) * | 1987-12-21 | 1989-12-12 | W. R. Grace & Co.-Conn. | Contact lenses based on biocompatible polyurethane and polyurea-urethane hydrated polymers |
US4888012A (en) * | 1988-01-14 | 1989-12-19 | Gerald Horn | Intraocular lens assemblies |
CS271606B1 (en) | 1988-04-11 | 1990-10-12 | Sulc Jiri | Intraocular optical system |
US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
US4994082A (en) | 1988-09-09 | 1991-02-19 | Ophthalmic Ventures Limited Partnership | Accommodating intraocular lens |
EP0442953A4 (en) * | 1988-11-09 | 1991-10-30 | Elvin Merrill Bright | Optical plastics and methods for making the same |
US4946899A (en) * | 1988-12-16 | 1990-08-07 | The University Of Akron | Thermoplastic elastomers of isobutylene and process of preparation |
US6197059B1 (en) | 1990-04-27 | 2001-03-06 | Medevec Licensing, B.V. | Accomodating intraocular lens |
US5047051A (en) | 1990-04-27 | 1991-09-10 | Cumming J Stuart | Intraocular lens with haptic anchor plate |
US5634943A (en) | 1990-07-12 | 1997-06-03 | University Of Miami | Injectable polyethylene oxide gel implant and method for production |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5578081A (en) * | 1991-11-12 | 1996-11-26 | Henry H. McDonald | Eye muscle responsive artificial lens unit |
US5275623A (en) | 1991-11-18 | 1994-01-04 | Faezeh Sarfarazi | Elliptical accommodative intraocular lens for small incision surgery |
US6692525B2 (en) | 1992-02-28 | 2004-02-17 | Advanced Medical Optics, Inc. | Intraocular lens |
US5876438A (en) * | 1993-08-02 | 1999-03-02 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
US5789463A (en) * | 1994-06-07 | 1998-08-04 | Tomey Technology Corporation | Ocular lens material and process for producing the same |
US6063116A (en) * | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
US5607472A (en) * | 1995-05-09 | 1997-03-04 | Emory University | Intraocular lens for restoring accommodation and allows adjustment of optical power |
US5968058A (en) * | 1996-03-27 | 1999-10-19 | Optonol Ltd. | Device for and method of implanting an intraocular implant |
US5730156A (en) * | 1996-07-10 | 1998-03-24 | Mackool; Richard J. | Method for cutting and removing wrapping from an intraocular lens implant within an eye |
US5741331A (en) * | 1996-07-29 | 1998-04-21 | Corvita Corporation | Biostable elastomeric polymers having quaternary carbons |
FR2757064B1 (en) | 1996-12-13 | 2000-02-04 | Ioltechnologie Production | INTRAOCULAR LENS CONTAINING RELARGABLE MEDICINE |
FR2757061B1 (en) * | 1996-12-16 | 1999-03-26 | Rhone Merieux | AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS AS A VECTOR |
US6050970A (en) * | 1997-05-08 | 2000-04-18 | Pharmacia & Upjohn Company | Method and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye |
US6027531A (en) | 1997-10-14 | 2000-02-22 | Tassignon; Marie-Joseb. R. | Intraocular lens and method for preventing secondary opacification |
US6158862A (en) * | 1997-12-04 | 2000-12-12 | Alcon Laboratories, Inc. | Method of reducing glare associated with multifocal ophthalmic lenses |
AU737675B2 (en) | 1998-04-15 | 2001-08-30 | Alcon Laboratories, Inc. | Intraocular lens coating compositions |
US6726823B1 (en) * | 1998-11-28 | 2004-04-27 | Acm Research, Inc. | Methods and apparatus for holding and positioning semiconductor workpieces during electropolishing and/or electroplating of the workpieces |
US6176878B1 (en) * | 1998-12-17 | 2001-01-23 | Allergan Sales, Inc. | Accommodating intraocular lens |
US6106554A (en) * | 1999-02-25 | 2000-08-22 | Bausch & Lomb Surgical, Inc. | Intraocular lens implants for the prevention of secondary cataracts |
HUP0201111A3 (en) * | 1999-04-26 | 2004-05-28 | Gmp Vision Solutions Inc Ft La | Shunt device for treating glaucoma |
US6461384B1 (en) * | 1999-06-17 | 2002-10-08 | Bausch & Lomb Incorporated | Intraocular lenses |
US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6685741B2 (en) | 1999-07-29 | 2004-02-03 | Bausch & Lomb Incorporated | Intraocular lenses |
US6271281B1 (en) * | 1999-08-26 | 2001-08-07 | Medennium, Inc. | Homopolymers containing stable elasticity inducing crosslinkers and ocular implants made therefrom |
US6299641B1 (en) * | 1999-09-10 | 2001-10-09 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6645246B1 (en) * | 1999-09-17 | 2003-11-11 | Advanced Medical Optics, Inc. | Intraocular lens with surrounded lens zone |
US6599317B1 (en) * | 1999-09-17 | 2003-07-29 | Advanced Medical Optics, Inc. | Intraocular lens with a translational zone |
US6193750B1 (en) * | 1999-10-15 | 2001-02-27 | Medevec Licensing, B.V. | Collars for lens loops |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
CA2399406C (en) * | 2000-02-03 | 2009-01-20 | Accommo Ag | Lens implant |
US6391230B1 (en) | 2000-02-18 | 2002-05-21 | Bausch & Lomb Incorporated | Intraocular lens manufacturing process |
US6638239B1 (en) * | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US6660035B1 (en) * | 2000-08-02 | 2003-12-09 | Advanced Medical Optics, Inc. | Accommodating intraocular lens with suspension structure |
US20020111590A1 (en) * | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US6545097B2 (en) * | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
US6524340B2 (en) * | 2001-05-23 | 2003-02-25 | Henry M. Israel | Accommodating intraocular lens assembly |
US20030060878A1 (en) * | 2001-08-31 | 2003-03-27 | Shadduck John H. | Intraocular lens system and method for power adjustment |
JP4009185B2 (en) | 2001-11-30 | 2007-11-14 | 株式会社メニコン | How to make contact lenses |
US20030194421A1 (en) * | 2001-12-28 | 2003-10-16 | Angiotech Pharmaceuticals, Inc. | Treatment of uveitis |
US7150759B2 (en) * | 2002-01-14 | 2006-12-19 | Advanced Medical Optics, Inc. | Multi-mechanistic accommodating intraocular lenses |
US20050021139A1 (en) * | 2003-02-03 | 2005-01-27 | Shadduck John H. | Ophthalmic devices, methods of use and methods of fabrication |
US20070100445A1 (en) * | 2003-02-03 | 2007-05-03 | Shadduck John H | Intraocular lenses and business methods |
US6860601B2 (en) * | 2002-02-06 | 2005-03-01 | John H. Shadduck | Adaptive optic lens system and method of use |
US20030171809A1 (en) * | 2002-03-05 | 2003-09-11 | Phillips Andrew F. | Axial-displacement accommodating intraocular lens |
US6695881B2 (en) | 2002-04-29 | 2004-02-24 | Alcon, Inc. | Accommodative intraocular lens |
US6966649B2 (en) * | 2002-08-12 | 2005-11-22 | John H Shadduck | Adaptive optic lens system and method of use |
US20040056371A1 (en) * | 2002-09-25 | 2004-03-25 | Medennium, Inc. | Method of manufacturing ophthalmic lenses made from hydrophobic acrylic polymers |
US20040082993A1 (en) * | 2002-10-25 | 2004-04-29 | Randall Woods | Capsular intraocular lens implant having a refractive liquid therein |
US20040158323A1 (en) | 2002-11-20 | 2004-08-12 | Lisk James R. | Method for adjusting protein affinity of hydrophilic polymers |
US6836374B2 (en) * | 2002-11-20 | 2004-12-28 | Powervision, Inc. | Lens system and methods for power adjustment |
AU2004219674A1 (en) * | 2003-03-06 | 2004-09-23 | Powervision, Inc. | Adaptive optic lens and method of making |
US7166357B2 (en) * | 2003-03-20 | 2007-01-23 | Transitions Optical, Inc. | Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation |
US20050055075A1 (en) * | 2003-09-08 | 2005-03-10 | Leonard Pinchuk | Methods for the manufacture of porous prostheses |
EP1682196A2 (en) * | 2003-11-10 | 2006-07-26 | Angiotech International Ag | Medical implants and anti-scarring agents |
US20050137703A1 (en) * | 2003-12-05 | 2005-06-23 | Vanderbilt University | Accommodative intraocular lens |
US20050131535A1 (en) * | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
US20050168689A1 (en) * | 2004-01-30 | 2005-08-04 | Knox Carol L. | Photochromic optical element |
-
2004
- 2004-12-03 JP JP2006542770A patent/JP5009623B2/en not_active Expired - Fee Related
- 2004-12-03 AU AU2004297967A patent/AU2004297967C1/en not_active Ceased
- 2004-12-03 EP EP04812877.1A patent/EP1696831B1/en not_active Not-in-force
- 2004-12-03 WO PCT/US2004/040447 patent/WO2005057272A2/en active Application Filing
- 2004-12-03 US US11/004,538 patent/US7794498B2/en active Active
- 2004-12-03 CA CA2549191A patent/CA2549191C/en not_active Expired - Fee Related
-
2009
- 2009-06-11 US US12/482,857 patent/US20090312836A1/en not_active Abandoned
-
2011
- 2011-10-27 US US13/282,788 patent/US20120046743A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1696831B1 (en) | 2014-01-15 |
CA2549191C (en) | 2012-10-23 |
JP5009623B2 (en) | 2012-08-22 |
US7794498B2 (en) | 2010-09-14 |
US20050125059A1 (en) | 2005-06-09 |
WO2005057272A3 (en) | 2005-08-25 |
EP1696831A2 (en) | 2006-09-06 |
WO2005057272A2 (en) | 2005-06-23 |
EP1696831A4 (en) | 2007-03-07 |
AU2004297967A1 (en) | 2005-06-23 |
AU2004297967C1 (en) | 2011-10-27 |
US20090312836A1 (en) | 2009-12-17 |
US20120046743A1 (en) | 2012-02-23 |
JP2007512917A (en) | 2007-05-24 |
AU2004297967B2 (en) | 2011-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2549191A1 (en) | Improved ocular lens | |
USRE36150E (en) | Deformable-elastic intraocular lens | |
JP2606691B2 (en) | Improved intraocular lens structure having polyimide tactile portion and method of processing the same | |
RU2717083C2 (en) | Composition for making intraocular lens (iol) and method of making such lens | |
CA2916452C (en) | Shape memory polymer intraocular lenses | |
WO2001013972A1 (en) | Homopolymers containing crosslinkers and ocular implants made therefrom | |
ES2785637T3 (en) | Cinnamic alcohol-based, hydrophobic, acrylic copolymer for intraocular lenses | |
JP2007512917A5 (en) | Improved intraocular lens | |
JP2007262414A (en) | Polymer composition and ophthalmic lens main body | |
TW200930418A (en) | Ophthalmic and otorhinolaryngological device materials | |
ES2380894T3 (en) | Acrylic polymer material, hydrophobic for intraocular lens, of improved flexibility by the use of a transfer agent Acrylic polymer material, hydrophobic for intraocular lens, of improved flexibility by the use of a transfer agent | |
AU741716B2 (en) | High refractive index ophthalmic device materials | |
JP2001512754A (en) | Ophthalmic lens polymer | |
EP0872251B1 (en) | Method of sterilizing intraocular lens by electron beam | |
AU661306B2 (en) | Deformable-elastic intraocular lens | |
EP3068812B1 (en) | Process for producing a hydrophobic acrylic polymer material for an ophthalmic device | |
ES2935731T3 (en) | Shape-changing photosensitive polymeric composition for tinted optical lenses | |
US20140277438A1 (en) | Crystalline polymeric compositions for ophthalmic devices | |
BR112013032751A2 (en) | memory-shaped polymer intraocular lenses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20161205 |